AMLX - Amylyx Pharmaceuticals, Inc.
15.05
0.940 6.246%
Share volume: 1,285,694
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$14.11
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-04-2025 | 05-08-2025 | 11-06-2025 | |
| Cash flow financing | 131.000 K | 27.000 K | 80.000 K | 110.000 K | 65.662 M | 191.606 M | |
| Other financing cash flows | 131.000 K | 27.000 K | 80.000 K | 110.000 K | 85.000 K | 495.000 K | |
| Cash flow | 461.000 K | -95.514 M | -2.674 M | 6.082 M | -17.821 M | 166.474 M | |
| Net income | -118.793 M | -72.700 M | -72.704 M | -37.546 M | -35.907 M | -34.386 M | |
| Depreciation | 315.000 K | 208.000 K | 221.000 K | 160.000 K | 156.000 K | 120.000 K | |
| Changes in inventories | 9.253 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 819.000 K | -28.961 M | 38.816 M | 64.980 M | -43.659 M | 5.236 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 67.000 K | 89.000 K | -19.000 K | 20.000 K | 11.000 K | 24.000 K | |
| Cash Change | 351.000 K | -95.553 M | -2.438 M | 5.557 M | -17.624 M | 166.625 M |